Clinical Trials

NCT Number: NCT03808077 Phase: Phase 2 Trial Summary: The purpose of this study is to determine if there is a difference in intra-abdominal pressure which surgeons use during surgery and post-surgery pain in men who undergo robotic pr – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Memorial Sloan Kettering Cancer Center Acronym:

NCT Number: NCT03769766 Phase: Phase 3 Trial Summary: This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveil – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Texas Southwestern Medical Center Acronym:

NCT Number: NCT03802851 Phase: Not Applicable Trial Summary: To determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Kansas Medical Center Acronym: HOLEP-RTPC

NCT Number: NCT03822494 Phase: Not Applicable Trial Summary: Stereotactic body radiation therapy (SBRT) has been employed in the treatment of prostate cancer. Multiple single institution experiences suggest high biochemical control rates wit – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Crozer-Keystone Health System Acronym: CK-DESPOT

NCT Number: NCT03697148 Phase: Not Applicable Trial Summary: This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate canc – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Acronym:

NCT Number: NCT03716739 Phase: PHASE2 Trial Summary: The purpose of this phase II trial is to determine the efficacy and safety of testosterone replacement therapy (TRT) in improving the symptoms of androgen deficiency and health-rel – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Dana-Farber Cancer Institute Acronym:

NCT Number: NCT03585660 Phase: NA Trial Summary: The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identi – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Chicago Acronym:

NCT Number: NCT03568656 Phase: Phase 1|Phase 2 Trial Summary: A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 in patients with metastatic castration resistant prostate cancer, metastatic breast can – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): CellCentric Ltd. Acronym:

NCT Number: NCT03496805 Phase: PHASE2 Trial Summary: It is estimated that one-third of the more than 7 million deaths from cancer worldwide are attributable to potentially modifiable risk factors, with 374,000 deaths preventable thro – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Wake Forest University Health Sciences Acronym:

NCT Number: NCT03424850 Phase: Phase 1|Phase 2 Trial Summary: The purpose of this research study is to learn more about the outcomes and early and late side effects of treating early stage prostate cancer with high dose rate brachyt – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Washington University School of Medicine Acronym: